Evidence map›Paper›PMID 41100016›Full record

ArticleDiscover nano2025

Mosquito repellency of carvacrol, thymol, and cinnamaldehyde nanogels against Aedes aegypti: a comparative study with DEET.

Samin Gheibi, Alireza Sanei-Dehkordi, Mojdeh Safari, Mahdi Nasiri-Ghiri, Sara Soleimani, Mahmoud Osanloo

Abstract read
In one paragraph

Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samin GheibiStudent Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
Alireza Sanei-DehkordiInfectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Mojdeh SafariFinetech in Medicine Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mahdi Nasiri-GhiriStudent Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
Sara SoleimaniDepartment of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Mahmoud OsanlooDepartment of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran. osanloo_mahmood@yahoo.com.ORCID http://orcid.org/0000-0002-1190-6874

Funding

Fasa University of Medical Sciences 402291
6 · The paper itself

Abstract

Aedes aegypti is a primary vector of arboviral diseases, including chikungunya, dengue fever, yellow fever, and Zika virus. Given the increasing global burden and the limitations of synthetic repellents, there is a growing need for safe and effective botanical alternatives, especially in endemic regions. This study formulated thymol-, carvacrol-, and cinnamaldehyde-loaded nanoemulsions via spontaneous emulsification and subsequently gelled using hydroxypropyl methylcellulose (HPMC). Viscosity and encapsulation efficiency were assessed using viscometry and Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectroscopy. The repellent efficacy of the resulting nanogels against Ae. aegypti was assessed and benchmarked against DEET (40% w/v). The nanoemulsions exhibited particle sizes of 208 ± 5 nm, 183 ± 6 nm, and 193 ± 4 nm for thymol, carvacrol, and cinnamaldehyde, respectively. Among all formulations, carvacrol-based nanogel (3% w/v) demonstrated the longest protection time (250 ± 34 min), exceeding the commercial DEET formulation (190 ± 17 min). These findings highlight the potential of HPMC-based nanogel repellents, particularly those containing carvacrol, as effective and safer botanical alternatives to conventional repellents, with promising implications for integrated vector management strategies.

Indexed as

Aedes aegyptiBotanical repellentNanoformulationsVector control

Identifiers

PMID41100016
PMCPMC12532507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.